SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the Regulation 24A of Listing Regulations read with relevant Circulars issued by the Securities and Exchange Board of India from time to time, we hereby submit, the ''Annual Secretarial Compliance Report'' of the Company for the year ended March 31, 2023 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provisions of Regulation 47 of the Listing Regulations, please find enclosed the copies of advertisement published on May 23, 2023, for the extract of Audited Financial Results of the Company for the quarter and year ended March 31, 2023 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the Listing Regulations, we hereby submit disclosure of Related Party Transactions for the half year ended March 31, 2023 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Statement On Deviation Or Variation In The Use Of Proceeds Of Preferential Issue For The Quarter Ended March 31, 2023
Statement on deviation or variation in the use of proceeds of Preferential Issue for the quarter ended March 31, 2023 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Raising of Funds
The Board of Directors of the Company at its meeting held today i.e. May 22, 2023, inter alia, have considered and approved for seeking approval from the shareholders of the Company by passing an enabling special resolution at the ensuing Annual General Meeting for Fund Raising SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. May 22, 2023
The Board of Directors of the Company at its meeting held today i.e. May 22, 2023, inter alia, have 1. considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2023. 2. considered and approved for seeking approval from the shareholders of the Company by passing an enabling special resolution at the ensuing Annual General Meeting for Fund Raising SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Audited Financial Results For The Quarter And Year Ended March 31, 2023
Audited Financial Results for the quarter and year ended March 31, 2023 SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Update on board meeting
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 ,inter alia, to consider and approve The Board at its meeting to be held on May 22, 2023 will also consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Considering And Approving The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2023 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2023